Kidney Test Expansion Aimed to Lower Heart Risk
A new global initiative seeks to increase usage of urine albumin tests to detect early signs of vascular damage in at-risk patients.
Updated on Sept. 22, 2026 in Heart Disease
Live Poll
Would you ask your doctor for specific screening tests to detect hidden heart or kidney risks?
Boehringer Ingelheim has expanded its Detect the SOS mission globally to promote the use of urine albumin-to-creatinine ratio (uACR) testing. The initiative aims to catch early signs of cardiovascular complications in individuals with hypertension and type 2 diabetes.
Why it matters
More than half of patients at risk for chronic kidney disease currently miss out on this screening, which serves as a critical early warning sign of vascular damage. By increasing testing, health systems hope to better identify patients at high risk of heart failure and death before severe symptoms emerge.
Clinical data indicates that a uACR level of 30 mg/g is a strong threshold for increased cardiovascular risk. Researchers have determined these elevations correlate with significantly higher incidences of heart-related mortality and cardiac events in at-risk populations.
The players
Boehringer Ingelheim
A global pharmaceutical company focused on human and animal health, specifically in cardiovascular and metabolic diseases.
World Heart Federation
A Geneva-based non-governmental organization working to reduce the burden of cardiovascular disease worldwide.
European Kidney Patients Federation
An advocacy group representing kidney patients across Europe to improve standards of care and early detection.
Mended Hearts Europe
A patient support organization providing resources and advocacy for individuals living with heart disease.
The details
The uACR test identifies albuminuria, which is a condition where the kidneys leak protein into the urine and serves as a primary indicator of systemic vascular damage. Detecting these leaks allows clinicians to identify high-risk patients who may not yet show standard heart symptoms. The mission advocates for integrating this simple urine test into routine primary-care health visits to capture patients who are currently overlooked.
Timeline
September 28, 2026: EU Screening Week commences.
September 29, 2026: World Heart Day campaign begins.
Health Landscape
The global standard of care for patients with hypertension and type 2 diabetes has increasingly emphasized the link between renal function and cardiac health. This initiative follows a pattern established by the Detect the SOS mission to address the gap between proven diagnostic guidelines and actual clinical practice.
If you are managing hypertension or type 2 diabetes, you may want to ask your primary care provider if a uACR urine test is appropriate for your screening schedule. Being aware of your albumin levels can help your doctor better assess your overall cardiovascular risk profile.
The takeaway
Early detection through simple urine screening can reveal hidden damage to your vascular system long before severe heart complications occur. Consider discussing your risk factors for chronic kidney disease with your physician to determine if regular protein-to-creatinine testing is right for you.
What happens next
The mission will intensify its advocacy efforts through participation in the upcoming EU Screening Week on September 28, 2026, and the World Heart Day campaign on September 29, 2026.
Further reading
For more on managing heart health, visit our Heart Disease section.
Live Poll
Would you ask your doctor for specific screening tests to detect hidden heart or kidney risks?
